Natural hallucinogens, such as psilocybin, mescaline, N,N-dimethyltryptamine (DMT) and related compounds, have generally ...
TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased to ...
Psilocybin, a serotonergic psychedelic, is being increasingly researched in clinical studies for the treatment of psychiatric disorders. The relatively lengthy duration of oral psilocybin’s acute ...
When people use a psychedelic called dimethyltryptamine (DMT), they experience a temporary loss of their sense of self. DMT interacts with a frequency of brain activity associated with ...
Twenty-seven healthy participants (12 men and 15 women; mean age 33 years; range: 25–58 years) were recruited by word of mouth or from a pool of volunteers who had contacted our research group because ...
Neuro-pharmaceutical company, MindMed, has announced that it will begin a double-blind placebo-controlled Phase 1 clinical trial to understand how N, N-Dimethyltryptamine (DMT), the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results